SABCS 2020: Dose Escalation of Neratinib Lessens Treatment-Associated Diarrhea in Breast Cancer
The modified regimen helps patients stay on neratinib longer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.